REBECCA MCWHIRTER: Open Payments
NPI 1902421746 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 45 payments from 14 companies in 2025. Trend: 2023 $787 · 2024 $858 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $185 |
| PFIZER INC. | 6 | $111 |
| ABBVIE INC. | 6 | $98 |
| Amgen Inc. | 5 | $94 |
| GlaxoSmithKline, LLC. | 5 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $90 |
| ACADIA Pharmaceuticals Inc | 2 | $55 |
| Lilly USA, LLC | 3 | $46 |
| Abbott Laboratories | 1 | $22 |
| Edwards Lifesciences Corporation | 1 | $22 |
Products named: XIFAXAN, Wegovy, UBRELVY, OTEZLA, Ozempic, DAYBUE, SHINGRIX, NURTEC ODT.
Industry payments across MS — which companies pay providers there.
